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Abstract 
Both maternal 25-hydroxyvitamin D [25(OH)D] concentrations during pregnancy and placental 2 
amino acid transporter gene expression have been associated with development of the offspring in 
terms of body composition and bone structure. Several amino acid transporter genes have vitamin D 4 
response elements in their promoters suggesting the possible linkage of these two mechanisms. We 
aimed to establish whether maternal 25(OH)D and vitamin D-binding protein (DBP) levels relate to 6 
expression of placental amino acid transporters. RNA was extracted from 102 placental samples 
collected in the Southampton Women’s Survey (SWS) and gene expression was analysed using 8 
quantitative real-time PCR. Gene expression data were normalised to the geometric mean of three 
housekeeping genes and related to maternal factors and childhood body composition. Maternal 10 
serum 25(OH)D and DBP levels were measured by radioimmunoassay. Maternal 25(OH)D and 
DBP levels were positively associated with placental expression of specific genes involved in 12 
amino acid transport. Maternal 25(OH)D and DBP concentrations were correlated with the 
expression of specific placental amino acid transporters and thus may be involved in the regulation 14 
of amino acid transfer to the fetus. The positive correlation of DBP levels and placental transporter 
expression suggests that delivery of vitamin D to the placenta may be important. This exploratory 16 
study identifies placental amino acid transporters which may be altered in response to modifiable 
maternal factors and provides a basis for further studies.  18 
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Introduction 
Vitamin D insufficiency is common in women of childbearing age and is associated with reduced 2 
fetal growth and poor postnatal health 
(12, 18)
. The biologically inactive 25-hydroxyvitamin D 
[25(OH)D] is used to monitor vitamin D status as this is the major circulating form 
(14)
. In the 4 
Southampton Women’s Survey (SWS), a prospective longitudinal study of maternal nutrition and 
lifestyle before and during pregnancy, lower maternal 25(OH)D was associated with morphological 6 
changes in the fetal femur 
(24)
, lower neonatal fat mass and greater fat mass and lower grip strength 
in childhood 
(8, 13)
. Reduced 25(OH)D during late pregnancy was also associated with reduced bone 8 
mineral content in children at 9 years of age in another Southampton cohort study 
(19)
. 
 10 
The mechanisms underlying these associations are not fully understood, but are likely to involve the 
placenta; the sole conduit for nutrition from mother to fetus. We previously reported that placental 12 
mRNA expression of the vitamin D sensitive calcium transporter PMCA3 and the imprinted gene 
PHLDA2 is associated with offspring bone mass development and composition 
(21, 25)
. Other than 14 
calcium transport, a key element for fetal bone development is placental amino acid transport. 
Placental amino acid transfer is vital for fetal growth 
(2)
 and animal studies suggest that decreased 16 
amino acid transport precedes fetal growth restriction 
(17)
. Amino acid transfer to the fetus involves 
amino acid transport across the microvillous (MVM) and basal membranes (BM) of the placental 18 
syncytiotrophoblast and potentially metabolic interconversion within the placenta 
(7, 9)
. Placental 
amino acid transfer is thought to be regulated by maternal nutritional and hormonal factors 
(10, 16, 29)
. 20 
 
There are three classes of amino acid transporter in the human placenta; accumulative transporters, 22 
amino acid exchangers 
(3, 22)
 and facilitated transporters 
(6)
 (Figure 1). The facilitated transporters 
TAT1, LAT3 and LAT4 are essential for net amino acid transport to the fetus and their gene 24 
expression in human placenta is associated with measures of fetal growth 
(6)
. The factors that 
regulate these changes in gene expression are not understood. However, as these and several other 26 
amino acid transporters have vitamin D response elements (VDRE) in their promoter regions they 
could theoretically be regulated at the transcriptional level by maternal vitamin D. Specifically the 28 
biologically active 1,25 dihydroxyvitamin D [1,25(OH)2D] regulates transcription of specific genes 
by binding the vitamin D receptor (VDR) and interacting with VDRE in their promoter regions.  30 
 
We therefore investigated whether maternal 25(OH)D and Vitamin D binding protein (DBP) 32 
concentrations during pregnancy are related to placental amino acid transporter gene expression in 
samples collected from a population based cohort: the Southampton Women’s Survey.   34 
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Methods 
The study was conducted according to the guidelines in the Declaration of Helsinki, and the 2 
Southampton and South West Hampshire Research Ethics Committee approved all procedures 
(276/97, 307/97, 089/99, 153/99, 005/03/t, 06/Q1702/104). Written informed consent was obtained 4 
from all participating women and by parents or guardians with parental responsibility on behalf of 
their children. 6 
 
Maternal measurements 8 
We used data and samples from the SWS, a cohort study of 3,158 pregnancies with information 
collected from the mothers before conception 
(15)
. Non-pregnant women aged 20-34 years were 10 
recruited via their General Practitioners; assessments of lifestyle, diet and anthropometry were 
performed by trained research nurses at study entry and then in early (11 weeks) and late (34 12 
weeks) gestation among those women who became pregnant. Subscapular skinfold thicknesses were 
measured to the nearest 0.1 mm in triplicate using Harpenden skinfold callipers 
(11)
.  14 
 
At 34 weeks of gestation, a maternal venous blood sample was obtained and an aliquot of maternal 16 
serum was frozen at -80°C. Serum 25(OH)D and DBP concentrations were analyzed by 
radioimmunoassay (Diasorin, Stillwater, MN). The 25(OH)D assay measures both 25-18 
hydroxyvitamin D2 and 25-hydroxyvitamin D3. The assays met the requirements of the UK 
National Vitamin D External Quality Assurance Scheme, and intra- and inter-assay coefficients of 20 
variance were <10%. 
 22 
Placental samples 
Placentas were collected from term pregnancies within 30 minutes of delivery. Placental weight was 24 
measured after removing blood clots, cutting the umbilical cord flush with its insertion into the 
placenta, trimming away surrounding membranes and removing the amnion from the basal plate. To 26 
ensure that samples collected were representative of the placentas as a whole, 5 villous tissue 
samples were selected using a stratified random sampling method and stored at -80°C. For this 28 
study, a cohort of 102 placentae was selected from 300 collected in total based on availability of 
neonatal dual energy X-ray absorptiometry (DXA) data. 30 
 
RNA extraction and cDNA synthesis 32 
For each placenta 5 snap frozen samples were pooled and powdered in a frozen tissue press. Total 
RNA was extracted from 30 mg powdered placental tissue using the RNeasy fibrous tissue RNA 34 
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isolation mini kit (Qiagen, UK) according to the manufacturer’s instructions. The integrity of total 
RNA was confirmed by agarose gel electrophoresis.  2 
 
Total RNA (0.2 µg) was reverse transcribed with 0.5 µg random hexamer primer, 200 units (u) M-4 
MLV reverse transcriptase, 25 u recombinant RNasin ribonuclease inhibitor and 0.5 mM each of 
dATP, dCTP, dGTP and dTTP in a final reaction volume of 25 µl in 1x MMLV reaction buffer 6 
(Promega, Wisconsin, USA). All 102 samples were produced in one batch to reduce variation.  
 8 
Probe and primer design 
Intron spanning oligonucleotide probes and primers were designed using the Roche (West Sussex, 10 
UK) ProbeFinder version 2.45 for human. Probes were supplied by Roche from the human 
universal probe library and primers were synthesised by Eurogentec (Seraing, Belgium). Control 12 
genes were selected using the geNormTM human Housekeeping Gene Selection Kit (Primer Design 
Limited, Southampton, UK).  14 
 
Target genes 16 
The genes measured in this study along with primer and probe details are listed in Table 1. mRNA 
levels were measured using quantitative real-time PCR using a Roche LightCycler 480. For Roche 18 
universal probe library probes the cycle parameters were 95
o
C for 10 min, followed by 40 cycles of 
95
o
C for 15 s and 60
o
C for 1 min. For the Primer Design Perfect Probes the cycle parameters were 20 
95
o
C for 10 min, followed by 40 cycles of 95
o
C for 10 s and 60
o
C and 72
o
C for 15 s. Intra-assay 
CV’s for each gene were 5-8%. Each of the 102 samples was run on the same plate in triplicate. All 22 
mRNA levels are presented relative to the geometric mean of the three control genes, tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), 24 
ubiquitin C (UBC) and topoisomerase (TOP1) 
(4)
.  
 26 
Postnatal measurements 
At birth (n = 102) and 4 years of age (n = 42-46) a whole-body DXA scan was obtained using a 28 
Hologic Discovery instrument (Hologic Inc) in pediatric scan mode (Apex 3.1 software), yielding 
fat mass, lean mass, and bone mineral content. The coefficient of variation for body composition 30 
analysis with the DXA instrument was 1.4% to 1.9%. 
 32 
Statistics 
Maternal and placental mRNA data that were not normally distributed were transformed 34 
logarithmically. Previous data showed that gene expression of the control genes and many of the 
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target genes was higher in male than in female placentae 
(5)
. Adjustment was therefore made for sex 
in the correlation analysis between mRNA and all other variables. Pearson’s correlation coefficient 2 
(rp) was used to determine partial correlations adjusted for sex and gestational age between 
placental mRNA levels, neonatal body composition and maternal factors (IBM SPSS Statistics 20, 4 
USA). The partial correlation between placental gene expression and maternal vitamin D measures 
was also adjusted for potential confounding factors: maternal sum of skinfold thickness, walking 6 
speed, parity and smoking during pregnancy. A value of p < 0.05 was accepted as statistically 
significant, and, given the observational nature of the study together with the substantial co-linearity 8 
among both predictors and outcomes, testing for multiple comparisons was felt to be inappropriate 
(28)
.  10 
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Results  
Characterisation of the subjects from the SWS cohort 2 
The mean age (SD) of the 102 mothers at the birth of their child was 30.9 (3.9) years; 37.9% were 
primiparous. The median (inter-quartile range) gestational age was 39.6 (38.8–40.7) weeks. The 4 
mean (SD) placental/fetal weight ratio was 0.13 (0.02). Of the 102 placentas from SWS pregnancies 
studied here, 53 of the infants were male and 49 were female.  6 
 
Maternal plasma vitamin D and placental gene expression 8 
34-week plasma 25(OH)D levels were measured for 91 of the 102 women and DBP levels for 85 of 
the 102 women. Of the genes investigated mRNA for EAAT1, EAAT4 and EAAT5 were not detected 10 
in human placenta.  
 12 
In this subset of SWS woman, there was a positive correlation between maternal 34-week plasma 
25(OH)D levels and the mRNA expression of LAT3, ASCT1 and y
+
LAT1 and a negative correlation 14 
with SNAT1 (Table 2). Maternal DBP levels correlated positively with mRNA expression of TAT1, 
LAT3,  LAT4, SNAT1, SNAT2, y
+
LAT2, 4F2HC, EAAT3 and there was a trend with LAT1 (Table 2). 16 
When the correlation was also adjusted for maternal confounding factors all correlations were still 
present except for the relationships between 25(OH)D and ASCT1 and DBP and TAT1 which were 18 
no longer statistical significant at the p < 0.05 level (Table 2). The adjusted data also showed a 
positive association between DBP and LAT1 mRNA (Table 2). 20 
 
Neonatal body composition 22 
At birth, there were no significant associations between placental amino acid transporter gene 
expression and neonatal lean mass, fat mass or bone mineral content (data not shown). 24 
At 4 years of age total lean mass was positively associated with y
+
LAT1, LAT3 and TAT1 mRNA 
expression (Table 3). Bone mineral density was positively associated with LAT4 mRNA and 26 
negatively associated with ASCT2 and EAAT3 mRNA expression (Table 3). EAAT3 mRNA 
expression levels (n = 42) were also negatively associated with bone mineral content (rp = -0.46, p = 28 
0.003) and total bone area (cm
2
 without heads; rp = -0.43, p = 0.01). SNAT4 (rp = -0.40, p = 0.01) 
and y
+
LAT2 (rp = -0.32, p = 0.04) expression levels were negatively associated with total bone area. 30 
Page 8 of 18
Cambridge University Press
British Journal of Nutrition
For Review Only
 
8 
 
Discussion 
Many genes related to placental function may be regulated directly or indirectly by vitamin D. This 2 
study aimed to establish whether there are relationships between maternal vitamin D levels and 
changes in gene expression in placentas from the SWS. Maternal 25(OH)D and DBP levels were 4 
positively associated with placental expression of genes involved in amino acid transport. This 
suggests that maternal vitamin D status may regulate the expression of placental amino acid 6 
transporters and potentially influence the transfer of amino acids to the fetus and subsequent fetal 
growth. The observations that DBP was associated with the expression of twice as many genes as 8 
vitamin D suggests that delivery of vitamin D to the placenta may be a crucial determinant of 
vitamin D activity. The associations seen may however involve a more complex relationship 10 
between maternal vitamin D status and maternal body composition.  
 12 
Vitamin D 
Placental amino acid transport is important for fetal growth and development, so understanding how 14 
the amino acid transporters are regulated in the placenta will help us understand the mechanisms 
underlying fetal growth restriction and the associated postnatal phenotype. Maternal vitamin D 16 
status has also been shown to associate with both fetal and neonatal growth, and, taken with the fact 
that it modulates gene transcription; this suggests there may be an interaction between vitamin D 18 
and placental amino acid transport. This interaction could be a direct effect of vitamin D and its 
receptor acting directly on the placental amino acid transporter genes at a VDRE or an indirect 20 
effect mediated via vitamin D’s activation of another gene. Both the LAT3 and ASCT1 genes have 
been shown to have VDREs in their promoter region 
(31)
 which could underlie the association 22 
between their mRNA expression and maternal 25(OH)D levels. Vitamin D can also down regulate 
gene expression via VDR blocking the activity of the cyclic AMP response element (CRE) in the 24 
promoter 
(32)
. This may explain the observed negative association between 25(OH)D and SNAT1 
mRNA expression; a gene regulated by cyclic AMP at the CRE 
(27)
. Vitamin D can also directly 26 
affect gene transcription by an interaction between VDR and histone acetyltransferases leading to 
an open/active chromatin state 
(20)
. The amino acid transporter genes could therefore be in a region 28 
of DNA affected by vitamin D mediated epigenetic changes or could be regulated indirectly via an 
effect on another gene in the placenta. 30 
 
The relationship between vitamin D and placental function may be more complex than VDR 32 
mediated changes in placental gene expression and could be very indirect via an effect on maternal 
physiology or metabolism. It could be that vitamin D levels are influencing aspects of the maternal 34 
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environment which in turn regulate placental gene expression. Alternatively, maternal factors could 
simply be regulating both vitamin D levels and placental amino acid transporter expression in a 2 
similar manner. Plasma vitamin D status is known to be related to factors such as maternal smoking, 
parity and body mass index (BMI) 
(30)
. It could be that maternal body composition is influencing the 4 
placenta as a signal reflecting the mother’s nutrient reserves and capacity to support the pregnancy. 
We have previously demonstrated an association between maternal muscle mass and placental 6 
amino acid transfer indicating that maternal body composition can affect placental amino acid 
handling 
(23)
.  8 
 
Vitamin D levels could therefore be a proxy for another aspect of the maternal environment and not 10 
a direct mediator of amino acid transporter expression levels. When we corrected our correlation 
analysis to adjust for maternal factors we did indeed see that the amino acid transporters ASCT1 and 12 
SNAT1 no longer related to the maternal 25(OH)D levels. These transporters may therefore be 
regulated by aspects of maternal body composition rather than vitamin D status, or vitamin D levels 14 
may be mediating the effects of body composition on the placenta. LAT3 and y
+
LAT1 did still show 
strong associations with maternal 25(OH)D levels suggesting it is the vitamin D rather than body 16 
composition affecting their regulation. Further studies are needed to establish the mechanisms 
underlying this association. 18 
 
Interestingly there were a number of positive associations between DBP and amino acid transporter 20 
expression levels. This suggests that the delivery of the vitamin D to the placenta by its binding 
protein may be an important determinant of vitamin D action, possibly mediated by receptor 22 
mediated endocytosis 
(26)
. Further investigation into the uptake of vitamin D and levels of the active 
1,25(OH)2D within the placenta are needed. This will help us understand and improve the effects of 24 
25(OH)D supplementation during pregnancy, which may also require the DBP to be upregulated.  
 26 
Postnatal outcome 
We previously reported that placental TAT1 and LAT3 mRNA expression levels in this cohort are 28 
positively related to measures of fetal growth, with TAT1 mRNA being associated with fetal growth 
in terms of lean mass 
(6)
. Consistent with these observations we found that y
+
LAT1, TAT1 and LAT3 30 
mRNA expression in placentas are positively related to 4 year old lean mass. As lean mass contains 
a high proportion of muscle, a protein rich tissue, its growth will require a substantial amino acid 32 
supply so may rely on appropriate amino acid supply in early development.  
 34 
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Limitations 
This study has the advantage of using a well characterised population representative of the general 2 
population, with detailed phenotyping of mother-offspring pairs. However, the exploratory nature of 
this study, small sample size and the possibility of chance findings need to be acknowledged. 4 
Compared to adults, DXA assessment of body composition in children is more problematic due to 
their smaller size and tendency to move. These DXA measures have however been validated 6 
previously in piglets using biochemical assessment of carcass nitrogen content and lipid extraction 
to determine lean and fat mass, respectively 
(1)
. In this study specific paediatric software was used 8 
and movement artefacts were minimal. It is not possible in this observational study to determine 
whether the observed associations are causal. Nevertheless, the patterns of observations are 10 
indicative of a role for vitamin D in the regulation of placental amino acid transporter expression 
and form the basis for future studies.  12 
 
Conclusion 14 
In conclusion this study demonstrates relationships between maternal vitamin D levels and in 
particular vitamin D binding protein and placental gene expression. As there are associations 16 
between vitamin D and body composition these observations provide a possible mechanism by 
which maternal factors influence placental function. Further work needs to be undertaken to 18 
investigate the association between maternal vitamin D binding protein and placental gene 
expression and whether these are direct or indirect effects. 20 
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Figure Legends: 
Figure 1: Transport of amino acids across the placental syncytiotrophoblast. Amino acids are transported across 2 
the microvillous membrane (MVM) into the placental syncytiotrophoblast by active accumulative transporters (Ac; e.g. 
SNATs) and exchangers (X; e.g. ASCTs). Amino acids transported by accumulative transporters (aaA) are then 4 
exchanged back for those only transported by exchangers (aaB). Amino acids are transported out of the placenta across 
the basal membrane (BM) by facilitated transporters (TAT1, LAT3 & 4) and exchangers (X). The facilitated 6 
transporters transport specific amino acids (aa1) down their concentration gradient to the fetus. In order to transport 
other amino acids (aa2) to the fetus, aa1 must be exchanged for aa2 via exchangers (X).  8 
 
Figure 2: LAT3 mRNA expression is associated with postnatal body composition. LAT3 relative mRNA expression 10 
in human placenta is positively correlated with maternal 25(OH)D (A; rp = 31, p = 0.003, n = 102) and lean mass at 4 
years of age (B; rp = 38, p = 0.01, n = 46).12 
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Table 1: Information on genes, primers and probes 
 2 
Transporter Gene Gene ID Genebank  
accession #  
Primers Roche universal  
probe library # 
ASCT1 SLC1A4 6509 NM_003038.2 F-5′-tttgcgacagcatttgctac-3’ 
R-5′-gcacttcatcatagagggaagg-3’ 
78 
ASCT2 SLC1A5 6510 NM_005628.2 
NM_001145144.1 
F-5′-gaggaatatcaccggaacca-3’ 
R-5′-aggatgttcatcccctcca-3’ 
43 
EAAT1 SLC1A3 6507 NM_004172.4 F-5′-ttgaactgaacttcggacaaatta-3’ 
R-5′-attccagctgccccaatact-3’ 
76 
EAAT2 SLC1A2 6506 NM_004171.3 F-5′-aaaatgctcattctccctctaatc-3’ 
R-5′-gccactagccttagcatcca-3’ 
78 
EAAT3 SLC1A1 6505 NM_004170.4 F-5′-agttgaatgacctggacttgg-3’ 
R-5′-gcagatgtggccgtgatac-3’ 
9 
EAAT4 SLC1A6 6511 NM_005071.1 
 
F-5′-tgcagatgctggtgttacct-3’ 
R-5′-gttgtccagggatgccata-3’ 
19 
EAAT5 SLC1A7 6512 NM_006671.4 F-5′-cgcccaggtcaacaactac-3’ 
R-5′-gctgcagtggctgtgatact-5’ 
9 
LAT1 SLC7A5 8140 NM_003486.5 F-5′-gtggaaaaacaagcccaagt-3’ 
R-5′-gcatgagcttctgacacagg-3’ 
25 
LAT2 SLC7A8 23428 NM_182728.1 
NM_012244.2 
F-5′-ttgccaatgtcgcttatgtc-3’ 
R-5′-ggagcttctctccaaaagtcac-3’ 
17 
LAT3 SLC43A1 8501 NM_003627.5 
NM_001198810.1 
F-5′-gccctcatgattggctctta-3’ 
R-5′-ccggcatcgtagatcagc-3’ 
29 
LAT4 SLC42A2 124935 NM_001284498.1 
NM_152346.2 
F-5′-acaagtatggcccgaggaa-3’ 
R-5′-gcaatcagcaagcaggaaa-3’ 
3 
SNAT1 SLC38A1 81539 NM_030674.3 
NM_001077484.1 
F-5′-attttgggactcgcctttg-3’ 
R-5′-agcaatgtcactgaagtcaaaagt-3’ 
47 
SNAT2 SLC38A2 54407 NM_018976.3 F-5′-cctatgaaatctgtacaaaagattgg-3’ 
F-5′-ttgtgtacccaatccaaaacaa-3’ 
9 
SNAT4 SLC38A4 55089 NM_018018.4 
NM_001143824.1 
F-5′-tgttctggtcatccttgtgc-3’ 
R-5′-aaaactgctggaagaataaaaatcag-3’ 
29 
TAT1 SLC16A10 117247 NM_018593.4 F-5′-ggtgtgaagaaggtttatctacagg-3′ 
R-5′-agggccccaaagatgcta-3′ 
6 
y
+
LAT1 SLC7A7 9056 NM_001126105.1 
NM_001126106.1 
F-5′-acactgccgtgagaacctg-3’ 
R-5′-aggagaggaaacccttcacc-3’ 
72 
y
+
LAT2 SLC7A6 9057 NM_001076785.1 
NM_003983.4 
F-5′-gctgtgatcccccatacct-3’ 
R-5′-ggcacagttcacaaatgtcag-3’ 
66 
4F2HC SLC3A2 
 
6520 NM_001012661.1 
 
F-5′-tggttctccactcaggttga-3’ 
R-5′-cagccaaaactccagagcat-3’ 
49 
 
4 
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Table 2: The associations between placental amino acid transporter mRNA expression and maternal serum 
25-hydroxyvitamin D and vitamin D binding protein levels. 2 
  34-week Vitamin D 
(nmol/l) 
Vitamin D binding 
protein (mg/dl) 
 34-week Vitamin D 
(nmol/l) 
Vitamin D binding 
protein(mg/dl) 
 r p r p r p r p 
TAT1 0.07 0.50 0.23 0.03 0.14 0.21 0.12 0.10 
LAT 3 0.31 0.003 0.22 0.04 0.37 0.003 0.22 0.05 
LAT 4 -0.12 0.25 0.28 0.01 -0.13 0.26 0.28 0.01 
SNAT1 -0.23 0.03 0.25 0.02 -0.20 0.07 0.23 0.05 
SNAT2 0.01 0.96 0.23 0.03 0.04 0.70 0.23 0.04 
SNAT4 0.14 0.19 0.08 0.45 0.12 0.30 0.12 0.29 
ASC1 0.23 0.03 0.06 0.62 0.20 0.07 0.11 0.33 
ASC2 0.04 0.74 0.18 0.10 0.05 0.63 0.17 0.14 
y+LAT1 0.31 0.003 0.03 0.81 0.36 0.001 0.02 0.99 
y+LAT2 0.04 0.73 0.26 0.02 -0.08 0.94 0.33 0.003 
EAAT2 0.12 0.26 -0.07 0.53 0.06 0.56 -0.01 0.91 
EAAT3 0.09 0.39 0.30 0.01 0.12 0.24 0.29 0.009 
LAT1 -0.14 0.19 0.21 0.06 -0.17 0.12 0.23 0.04 
LAT2 -0.08 0.44 0.18 0.10 -0.07 0.54 0.17 0.14 
4F2HC -0.12 0.26 0.25 0.02 -0.08 0.48 0.23 0.04 
 Adjusted for sex and dGA Adjusted for sex, dGA and  maternal confounding factors 
 
Table 3: The associations between placental amino acid transporter mRNA expression and 4 year old DXA 4 
measurements of body composition. 
4 year DXA Total lean (kg) (n = 46) Total Prentice BMD (g), without heads (n = 42) 
 r p r p 
TAT 1 0.33 0.03 -0.17 0.28 
LAT 3 0.38 0.01 -0.15 0.33 
LAT 4 -0.09 0.57 0.41 0.01 
SNAT1 -0.12 0.45 0.06 0.72 
SNAT2 0.06 0.68 -0.11 0.49 
SNAT 4 0.08 0.62 -0.18 0.26 
ASCT1 0.23 0.13 -0.27 0.09 
ASCT2 0.24 0.11 -0.42 0.01 
y+LAT1 0.31 0.04 -0.25 0.11 
y+LAT2 0.20 0.18 -0.27 0.09 
EAAT2 0.28 0.07 0.04 0.82 
EAAT3 -0.04 0.80 -0.59 0.00005 
LAT1 -0.21 0.16 0.09 0.59 
LAT2 -0.04 0.82 -0.02 0.90 
4F2HC 0.05 0.73 0.14 0.38 
 6 
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